Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 918 | 890 | 918 | 871 | 1045 | 1291 |
Fund Return | -8.24% | -10.97% | -8.24% | -4.5% | 0.89% | 2.58% |
Place in category | 153 | 142 | 153 | 102 | 75 | 43 |
% in Category | 74 | 77 | 74 | 56 | 55 | 48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1313519925 | 6B | 0.71 | 0.67 | - | ||
LU1300848345 | 6B | 0.98 | 0.97 | - | ||
LU1323611266 | 4.15B | 4.34 | 0.23 | - | ||
LU1520716801 | 4.15B | 7.31 | 2.63 | - | ||
UBS Equity S USA Growth USD I B acc | 2.96B | 33.24 | 8.81 | 15.92 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Franklin Biotech Discovery Nacc | 98.73M | 9.10 | 3.31 | 2.36 | ||
Equities L Biotechnology Class I US | 1.37B | 2.92 | 2.58 | 5.59 | ||
Equities L Biotechnology Class R US | 1.37B | 3.48 | 3.56 | 6.05 | ||
Candriam Equities Biotech C USD Cap | 1.37B | 2.56 | 2.68 | 5.20 | ||
LU0133359157 | 1.37B | 2.18 | 2.28 | 4.73 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 9.34 | 442.34 | +0.18% | |
Alnylam | US02043Q1076 | 6.68 | 277.54 | +1.30% | |
Neurocrine | US64125C1099 | 5.37 | 153.75 | +2.04% | |
Guardant Health | US40131M1099 | 4.39 | 49.30 | +3.46% | |
Amgen | US0311621009 | 4.25 | 285.04 | +1.19% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | BUY | BUY |
Summary | Strong Buy | Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review